摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Cyclopropyl-3-methoxy-propylamine | 512847-50-6

中文名称
——
中文别名
——
英文名称
1-Cyclopropyl-3-methoxy-propylamine
英文别名
1-Cyclopropyl-3-methoxypropan-1-amine
1-Cyclopropyl-3-methoxy-propylamine化学式
CAS
512847-50-6
化学式
C7H15NO
mdl
——
分子量
129.202
InChiKey
RWNOVNJPDXMCGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1-Cyclopropyl-3-methoxy-propylamineammonium hydroxide 、 sodium dithionite 作用下, 以 1,4-二氧六环乙腈 为溶剂, 生成 N2-(1-Cyclopropyl-3-methoxy-propyl)-4-(2,4-dichloro-phenyl)-pyridine-2,3-diamine
    参考文献:
    名称:
    Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands
    摘要:
    A series of high affinity CRF receptor ligands with an imidazo[4,5-b]pyridine core is described. Individual analogues were synthesized and tested in a rat CRF receptor binding assay. The best compounds were further tested in the dog N-in-1 pharmaco-kinetic model to assess plasma levels at 1 mg/kg (po) and in the rat situational anxiety model to assess anxiolytic efficacy at 3 mg/kg (po). The structure-activity relationships for good receptor binding affinity are described herein. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00833-8
  • 作为产物:
    描述:
    cyclopropyl methyl ketone oxime methyl ether 在 lithium aluminium tetrahydride 、 正丁基锂 作用下, 以 四氢呋喃 为溶剂, 生成 1-Cyclopropyl-3-methoxy-propylamine
    参考文献:
    名称:
    Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands
    摘要:
    A series of high affinity CRF receptor ligands with an imidazo[4,5-b]pyridine core is described. Individual analogues were synthesized and tested in a rat CRF receptor binding assay. The best compounds were further tested in the dog N-in-1 pharmaco-kinetic model to assess plasma levels at 1 mg/kg (po) and in the rat situational anxiety model to assess anxiolytic efficacy at 3 mg/kg (po). The structure-activity relationships for good receptor binding affinity are described herein. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00833-8
点击查看最新优质反应信息

文献信息

  • Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands
    作者:Argyrios G. Arvanitis、Joseph T. Rescinito、Charles R. Arnold、Richard G. Wilde、Gary A. Cain、Jung Hui Sun、Jia-Sheng Yan、Christopher A. Teleha、Lawrence W. Fitzgerald、John McElroy、Robert Zaczek、Paul R. Hartig、Scott Grossman、Stephen P. Arneric、Paul J. Gilligan、Richard E. Olson、David W. Robertson
    DOI:10.1016/s0960-894x(02)00833-8
    日期:2003.1
    A series of high affinity CRF receptor ligands with an imidazo[4,5-b]pyridine core is described. Individual analogues were synthesized and tested in a rat CRF receptor binding assay. The best compounds were further tested in the dog N-in-1 pharmaco-kinetic model to assess plasma levels at 1 mg/kg (po) and in the rat situational anxiety model to assess anxiolytic efficacy at 3 mg/kg (po). The structure-activity relationships for good receptor binding affinity are described herein. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多